health biotech news today obesity drugs glp-1 What to watch for in weight loss in 2026: Price changes, pills and more Healthy Returns: Obesity pills from

This technology can be applied to create genetically engineered bacteria which possess the ability to produce the GLP-1 protein once ingested orally

demand for protein ingredients , in fibre and with higher nutritional density, it is progressing

Then the weight loss results became undeniable, and things moved fast

We recommend assessing patients for GI symptoms attributable to GLP-1 receptor agonists, such as nausea, vomiting, dyspepsia, or changes in bowel habit

Journal of Radiation Research and Applied Sciences

reported greater weight loss in obese mice with the GLP-1/GIP/glucagon receptor triagonist compared to GLP-1 receptor agonists, GIP/GLP-1 receptor co-agonists and GLP-1/glucagon receptor agonists including semaglutide and tirzepatide [60]